On Wednesday, in the course of current trade, Shares of Kansas City Southern(NYSE:KSU), climbed 0.01%, and is now trading at $91.22.
Kansas City Southern, will release its financial results for second quarter 2015 on Friday, July 17, 2015, before the opening of trading on the New York Stock Exchange.
KCS will also hold its second quarter 2015 earnings conference call on Friday, July 17, 2015 at 8:45 a.m. eastern time. Shareholders and other interested parties are invited to take part via live webcast or telephone. To take part in the live webcast and to view accompanying presentation materials, please log into the KCS website at www.kcsouthern.com right away preceding to the presentation. To join the teleconference, please call (877) 407-0782 (U.S. and Canada), or (201) 689-8567 (International).
Kansas City Southern, through its auxiliaries, engages in the freight rail transportation business. It operates north/south rail route between Kansas City, Missouri, and various ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas in the midwest and southeast regions of the United States.
During an Afternoon trade, Shares of Navios Maritime Partners L.P. (NYSE:NMM), climbed 2.80%, and is now trading at $10.99.
Navios Maritime Partners, declared that the Navios Fantastiks, a 2005-built Capesize vessel, has been chartered out for a period of 16-20 months at a rate of $12,825 net per day to a high quality counterparty. The charter will commence in July.
Effective June 3, 2015, the Navios Fantastiks was chartered out to Navios Holdings for a ten-month period at a rate of $12,500 net per day with a 50% profit sharing based on actual results.
Navios Maritime Partners L.P. owns and operates dry cargo vessels in Europe, Asia, North America, and Australia. It provides seaborne transportation services for a range of drybulk commodities that comprise iron ore, coal, grain, and fertilizers, in addition to charters its vessels under medium to long-term charters.
Shares of Lion Biotechnologies Inc (NASDAQ:LBIO), during its Wednesday’s current trading session fell -0.01%, and is now trading at $9.17.
Lion Biotechnologies, declared that the FDA has granted orphan status to the company’s lead product candidate, LN-144, for the treatment of stage 2b to stage 4 malignant melanoma.
The FDA grants orphan status to novel drugs or biologics to treat rare medical diseases or conditions that affect fewer than 200,000 people in the United States. By receiving this designation for LN-144, Lion will be eligible for tax credits for clinical testing, exemption from a prescription drug user fee, and seven years of market exclusivity.
Lion Biotechnologies, a clinical-stage biopharmaceutical company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient’s immune system to eradicate cancer cells.
Finally, Empire State Realty Trust Inc (NYSE:ESRT), lost -0.06% Wednesday.
On Saturday, July 4, 2015, the Empire State Building (ESB) will host its annual Independence Day Celebration from 8:00 – 10:00 p.m. This exclusive annual event offers breathtaking views of the Greater New York City Region and the East River fireworks display from the world-famous 86th Floor Observatory.
Ticket holders will be given VIP private access to the 80th Floor “Dare to Dream” exhibit and 86th Floor Observatory, which will be closed to the general public at about 6:30 p.m. until 10:00 p.m. following the fireworks show. Light refreshments will be served, and a simulcast of the televised fireworks show will be accessible.
Empire State Realty Trust, Inc., a real estate investment trust (REIT), focuses on owning, managing, operating, and acquiring office and retail properties in Manhattan and the greater New York metropolitan area.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
